Reform Commission Investigates Inflated Drug Prices
This article was originally published in PharmAsia News
Executive Summary
In an emergency response to recent media coverage of inflated drug prices, the National Development and Reform Commission (NDRC) announced June 17 that it has already initiated price investigations for drugs on the Medicare drug catalogue